About
16.65USD+0.19 +1.15%
Closed • Updated at 20:44 GMT+00:00Market Cap$19.39B
Volume7.36M
Beta1.41
RSI60.83
Gross Margin38.90%
Viatris Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 7 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 4 2026
Viatris Announces Chief Financial Officer Transition
May 1 2026
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
May 1 2026
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
Community Chat
Ask AI
Try asking
Google Übersetzer